Sign up to save your podcasts
Or
Share The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce
A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Barron's
4.7
14891,489 ratings
A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Barron's Streetwise
View all
Motley Fool Money
3,221 Listeners
WSJ Your Money Briefing
1,721 Listeners
Investing Insights
523 Listeners
Exchanges
973 Listeners
Masters in Business
2,170 Listeners
Zacks Market Edge
295 Listeners
Wall Street Breakfast
1,040 Listeners
Schwab Market Update Audio
349 Listeners
Numbers by Barron's
378 Listeners
The Readback
212 Listeners
The Long View
904 Listeners
Thoughts on the Market
1,304 Listeners
Barron's Advisor
110 Listeners
Barron's Live
208 Listeners
Investing Experts
66 Listeners
The Markets
74 Listeners
WSJ's Take On the Week
146 Listeners
At Barron's
21 Listeners